List of Excipients in API BALSALAZIDE DISODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BALSALAZIDE DISODIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Salix Pharmaceuticals Inc | COLAZAL | balsalazide disodium | 65649-101 | MAGNESIUM STEARATE | |
| Salix Pharmaceuticals Inc | COLAZAL | balsalazide disodium | 65649-101 | SILICON DIOXIDE | |
| Oceanside Pharmaceuticals | BALSALAZIDE DISODIUM | balsalazide disodium | 68682-750 | MAGNESIUM STEARATE | |
| Oceanside Pharmaceuticals | BALSALAZIDE DISODIUM | balsalazide disodium | 68682-750 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BALSALAZIDE DISODIUM
Detailed excipient profiles for BALSALAZIDE DISODIUM
Excipient focus: AMMONIA
BALSALAZIDE DISODIUM drug variants containing AMMONIA
BALSALAZIDE DISODIUM drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | balsalazide disodium | 65649-101 |
| Oceanside Pharmaceuticals | balsalazide disodium | 68682-750 |
| Zydus Pharmaceuticals (USA) Inc | balsalazide disodium | 70710-1626 |
| Zydus Lifesciences Limited | balsalazide disodium | 70771-1841 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
BALSALAZIDE DISODIUM drug variants containing BUTYL ALCOHOL
BALSALAZIDE DISODIUM drug variants not containing BUTYL ALCOHOL
Excipient focus: FD&C BLUE NO. 1
BALSALAZIDE DISODIUM drug variants containing FD&C BLUE NO. 1
BALSALAZIDE DISODIUM drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
BALSALAZIDE DISODIUM drug variants containing FD&C RED NO. 40
BALSALAZIDE DISODIUM drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
BALSALAZIDE DISODIUM drug variants containing FD&C YELLOW NO. 6
BALSALAZIDE DISODIUM drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
BALSALAZIDE DISODIUM drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | balsalazide disodium | 42291-157 |
| AvPAK | balsalazide disodium | 50268-102 |
| Apotex Corp | balsalazide disodium | 60505-2575 |
| Bryant Ranch Prepack | balsalazide disodium | 63629-8301 |
| Bryant Ranch Prepack | balsalazide disodium | 72162-2095 |
| >Company | >Ingredient | >NDC |
BALSALAZIDE DISODIUM drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
BALSALAZIDE DISODIUM drug variants containing FERROSOFERRIC OXIDE
BALSALAZIDE DISODIUM drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
BALSALAZIDE DISODIUM drug variants containing GELATIN
BALSALAZIDE DISODIUM drug variants not containing GELATIN
Excipient focus: ISOPROPYL ALCOHOL
BALSALAZIDE DISODIUM drug variants containing ISOPROPYL ALCOHOL
BALSALAZIDE DISODIUM drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
BALSALAZIDE DISODIUM drug variants containing MAGNESIUM STEARATE
BALSALAZIDE DISODIUM drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
BALSALAZIDE DISODIUM drug variants containing PROPYLENE GLYCOL
BALSALAZIDE DISODIUM drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | balsalazide disodium | 65649-101 |
| Oceanside Pharmaceuticals | balsalazide disodium | 68682-750 |
| Zydus Pharmaceuticals (USA) Inc | balsalazide disodium | 70710-1626 |
| Zydus Lifesciences Limited | balsalazide disodium | 70771-1841 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
BALSALAZIDE DISODIUM drug variants containing SHELLAC
BALSALAZIDE DISODIUM drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | balsalazide disodium | 65649-101 |
| Oceanside Pharmaceuticals | balsalazide disodium | 68682-750 |
| Zydus Pharmaceuticals (USA) Inc | balsalazide disodium | 70710-1626 |
| Zydus Lifesciences Limited | balsalazide disodium | 70771-1841 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
BALSALAZIDE DISODIUM drug variants containing SILICON DIOXIDE
BALSALAZIDE DISODIUM drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
BALSALAZIDE DISODIUM drug variants containing TITANIUM DIOXIDE
BALSALAZIDE DISODIUM drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | balsalazide disodium | 65649-101 |
| Oceanside Pharmaceuticals | balsalazide disodium | 68682-750 |
| Zydus Pharmaceuticals (USA) Inc | balsalazide disodium | 70710-1626 |
| Zydus Lifesciences Limited | balsalazide disodium | 70771-1841 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
